White matter hyperintensities in Alzheimer's disease: Beyond vascular contribution

Cited by (139)

Items 101–139 of 139

1. Advances in imaging
   Emrah Düzel, Jose Bernal · 2025 · Elsevier eBooks
2. [18F]Florbetapir Pet Uptake Differences in White Matter Across the Alzheimer's Disease Continuum: From Cognitively Normal to MCI and Dementia
   Nigar Khasayeva, Kyle M. Jensen, Cyrus Eierud, Helen Petropoulos, Vince D. Calhoun, Armin Iraji · 2025 · IEEE International Symposium on Biomedical Imaging (ISBI)
3. Impact of Cardiometabolic Factors and Ad Plasma Biomarkers on White Matter Hyperintensities Volume in Individuals with Cognitive Complaints from the Global South
   Patricio Riquelme Contreras, Fernando Henríquez, Cecilia González Campo, Florencia Altschuler, Matías Fraile-Vazquez, Pâmela C.L. Ferreira, Bruna Bellaver, Thomas K. Karikari, Tharick Ali Pascoal, Graciela Muniz Terrera et al. · 2025 · SSRN Electronic Journal
4. Scratching Beneath the Cortex
   Mario Tranfa, Tiago Gil Oliveira · 2025 · Neurology
5. Evaluating the Predictive Value of Oxylipins for Cognitive Measures and White Matter Hyperintensities in Alzheimer’s Disease Continuum Compared to Conventional Beta‑amyloid and Tau Protein Biomarkers
   Alireza Shaabanpoor Haghighi, Mahsa Mayeli, Elham Ramezannezhad, Negin Pouroushaninia, Rezvan Barzegar Parizi, Mahtab Nourollahi-Foumeshi, Nasim Idelkhani, Zahra Dadjou, Niloofar Saeedipour, Negar Safaee et al. · 2025 · Molecular Neurobiology
6. Early-onset β-amyloidosis in human brains with hematological malignances and cardiovascular diseases: Revisiting injury/stress induced axonal pathology
   Yan Wang, Qi-Lei Zhang, Peng Zhou, Tian Tu, Zhong-Ping Sun, Xiao-Jie Zhang, Ewen Tu, Huiping Chen, Haiying Cheng, Aihua Pan et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
7. Alzheimer’s Disease Concurrent With Patent Foramen Ovale-Related Lacunar Infarcts and Extensive White Matter Hyperintensities: A Case Highlighting Biomarker-Clinical Staging Discordance
   Jieli Geng, Chenpeng Zhang, Nan Zhi, Xingchen Dai, Gang Wang · 2025 · Cureus
8. Investigating the impact of white matter hyperintensities on longitudinal progression in progressive supranuclear palsy
   Maria Francesca Tepedino, Francesco Diana, Anna Rosa Avallone, Maria Teresa Pellecchia, Sofia Cuoco, Marco Aiello, Renzo Manara, Paolo Barone, Marina Picillo · 2025 · Neurological Sciences
9. White Matter Hyperintensities in Relation to Cognition and Amyloid Burden in a South Korean Cohort With Subjective Cognitive Decline
   Eun Ye Lim, Jee Hyang Jeong, Kee Hyung Park, SangYun Kim, Min Jeong Wang, Yong Soo Shim, Seong Hye Choi, Dong Won Yang · 2025 · Alzheimer Disease & Associated Disorders
10. Detecting patterns of atrophy in cognitively impaired individuals using portable, low-field MRI
    Ava D. Farnan, Annabel Sorby‐Adams, Jennifer D. Guo, John R. Dickson, Liliana A Ramirez Gomez, Amanda DeSenna, JOHN E. KIRSCH, J.L. Smith, Emma Peasley, Jeremy N. Ford et al. · 2025 · Imaging Neuroscience
11. Higher spatial resolution diffusion-weighted imaging improves characterization of white matter disconnection in Alzheimer’s disease
    Jenna Louise Merenstein, Allen W. Song, Kim G. Johnson, Heather Elizabeth Whitson, David J. Madden · 2025 · Imaging Neuroscience
12. The international society of vascular behavioural and cognitive disorders: highlights from VasCog 2025 in the UK.
    Anna Marseglia, Roxana O. Carare, Jessica L. Teeling, Saima Hilal, Vera Yuan Cai, Russell Chander, Hugues Chabriat, Deborah Gustafson, Atticus H. Hainsworth, Gurpreet Kaur Hansra et al. · 2025 · Cerebral Circulation - Cognition and Behavior
13. RepAD: A Novel Deep Learning Framework for Robust and Interpretable Multiclass Classification of AD from Brain MRI Images
    Weijia Pan, He Wang, Zhaomin Yao · 2025 · Neuropharmacology and Therapy
14. Location patterns and longitudinal progression of white matter hyperintensities
    Xin Zhao, Ian B. Malone, Thomas McPherson Brown, Andrew Wong, David M. Cash, Nish Chaturvedi, Alun David Hughes, Jonathan M. Schott, Frederik Barkhof, Josephine Barnes et al. · 2026 · medRxiv
15. Stage-Dependent mediation of white matter hyperintensities between plasma biomarkers and cognitive function in Alzheimer’s disease
    Huijuan Chen, Yihao Guo, Weiyuan Huang, Kun Zhang, Tao Liu, Feng Chen · 2026 · Translational Psychiatry
16. Synergistic effects of cerebral small vessel disease burden and plasma phosphorylated tau 181 on white matter microstructure and cognition in a Chinese cohort
    Jingxian Xu, Haojie Chen, Yichen Wang, Zheqi Hu, Zhihong Ke, Lili Huang, Yuting Mo, Dan Yang, Chenglu Mao, Ying Chen et al. · 2026 · Brain Communications
17. Individual gray–white matter functional connection predicts tau spread and cognitive decline in Alzheimer’s disease
    Luyao Wang, Yiwen Gao, Jiaying Lu, Quanling Jiang, Huanxin Wang, Fan Dong, Qianhua Zhao, Yihui Guan, Xin Qi, Chuantao Zuo et al. · 2026 · NeuroImage
18. The moderation and mediation roles of white matter insults in relationship of APOE ε4 genotype with Alzheimer’s disease and related phenotypes: two longitudinal studies
    Kai-Zheng Liu, Xin‐Fu Zhou, Yuan-Fei Dong, Xinyu Luo, Lan Tan, Chen‐Chen Tan, Wei Xu · 2026 · Journal of Advanced Research
19. Brain atrophy and clinical diagnosis independently predict default mode network failure across the Alzheimer's disease continuum
    Mohammed Alghamdi, Frederic von Wegner, Daniel Kam Yin Chan, Michael Green, Alzheimer’s Disease Neuroimaging Initiative · 2026 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
20. Cerebral microbleeds are associated with white matter hyperintensities in patients with primary hypertension: A case–control study
    Wenhao Zhang, Xinlei Chen, Jinrong Li, Li Huang, En Xu, Qingyuan Lin, Lixuan Zhan · 2026 · Brain Circulation
21. Real-world clinical profile of individuals with cerebrospinal fluid Aβ – /pTau181 +
    Ophir Keret, Tianxu Xia, Sara Wilkins, Liqhwa Ncube, Briella Smaw, Yuguang Xiong, SE Gandy, Ana Pereira, Georges Naasan, Fanny M. Elahi · 2026 · Journal of Alzheimer s Disease
22. Investigation of the myelin-amyloid interplay in Alzheimer’s disease: insights from novel dsCMA imaging in mouse and human brains
    H X Xu, Sumit Nanda, Jiandong Sun, Mitchell Rudd, Lin Gou, Haley L. Marks, Christopher K. Williams, Shino Magaki, Harry V. Vinters, Houri Hintiryan et al. · 2026 · Acta Neuropathologica Communications
23. Discrete White Matter Lesions in Clusters and Harmony: Using Oblique Strategies to Study Brain Aging
    JAMES M. NOBLE, Adam M. Brickman · 2026 · Diabetes Care
24. Short T1 Fraction as a Marker of Myelin Content: Evidence from Postmortem MRI and Histology
    Chenyang Li, Dominique Leitner, Zifei Liang, Veronika Yakovishina, Merna Ibrahim, Arline Faustin, Thomas Wısnıewskı, Youssef Zaim Wadghiri, Yulin Ge, J Zhang · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
25. Bidirectional causal relationships between plasma proteins, neuroimaging metrics and risk of Alzheimer's disease
    Xu Xu, Lintong Li, Wei Huang, Ying Yang, Xu Li, Pei Wang, Mengmeng Zhao, Huiliang Zhang, Chaoming Yuan · 2026 · The Journal of Prevention of Alzheimer s Disease
26. Enlarged perivascular spaces in subcortical white matter are linked to amyloid–tau depositions and cognitive decline: Data from a memory clinic in Thailand
    Kittithatch Booncharoen, Poosanu Thanapornsangsuth, Thanakit Pongpitakmetha, Yuthachai Sarutikriangkri, Yuttachai Likitjaroen, Sekh Thanprasertsuk · 2026 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
27. Relationship between new-onset falls and neuroimaging markers of Alzheimer's disease in the UK Biobank
    Jacob S. Shaw, Michael J. C. Bray, Haris Iqbal Sair, Licia Luna, Katherine J. Hunzinger, Esther S. Oh, Paul B. Rosenberg, Matthew E. Peters · 2026 · Journal of Alzheimer s Disease
28. Beyond gray matter: unveiling the critical role of white matter in Alzheimer's disease
    Kexin Gao, Jiahui Bao, 宋友军, Ching‐Po Lin, Yasser Iturria‐Medina, Bharat B. Biswal, Pan Wang · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
29. The Associations of cerebral blood flow and white matter hyperintensities with tau and amyloid-beta across the Alzheimer’s disease spectrum
    Keshuo Lin, Perminder Singh Sachdev, Jiyang Jiang, Alzheimer’s Disease Neuroimaging Initiative · 2026 · Brain Imaging and Behavior
30. Intensive versus standard blood pressure control and overall brain small vessel disease burden: a post-hoc analysis of the SPRINT randomized clinical trial
    Sokratis Charisis, Nicholas M. Pajewski, Larry R. Price, Ngoc-Huynh Ho, Tanweer Rashid, David Wang, Yuheng Zeng, Niyas Shamsudeen Kutty, Robert Nick Bryan, Kyle C. Kern et al. · 2026 · EClinicalMedicine
31. Beyond amyloid: Contributions of neuroinflammation, cerebrovascular disease, and neurodegeneration to memory impairment in the oldest‐old, the LifeAfter90 Study
    Batool M. Rizvi, Pauline Maillard, Alexander Ivan B. Posis, Hilary Colbeth, Nancy X Chen, Adam M. Brickman, Paola Gilsanz, María M. Corrada, Rachel A. Whitmer · 2026 · Alzheimer s & Dementia
32. Choroid plexus volume in relation to volumetric and susceptibility characteristics of white matter hyperintensities in metabolic syndrome: a two-cohort MRI study
    Xinxin Huo, Linfeng Yang, Zhenyu Cheng, Boyao Chen, Fushuai Zhang, Yiwen Chen, Pengcheng Liang, Nan Zhang, Yena Che, Jiaxiang Xin et al. · 2026 · Research Square
33. Deep Learning–derived Bone Mineral Density and Longitudinal White Matter Microstructure and Cognitive Decline: Multi-Ethnic Study of Atherosclerosis
    Sara Momtazmanesh, Quincy Alexander Hathaway, Michael P. Bancks, David A. Bluemke, R. Graham Barr, Wendy S. Post, Mohamad Habes, Ilya M. Nasrallah, Susan R. Heckbert, Robert Nick Bryan et al. · 2026 · Radiology
34. Investigating Postmortem Blood Clots as Endogenous Contrast for Mesoscopic Cerebrovascular Mapping at 7 T
    Chenyang Li, Dominique Leitner, Huize Pang, Annie Li, Mary T. Bruno, Arline Faustin, Orrin Devinsky, Thomas Wısnıewskı, Youssef Zaim Wadghiri, Jiangyang Zhang et al. · 2026 · NMR in Biomedicine
35. Contribution of cerebrovascular lesions to neurodegeneration and cognitive decline
    Zhaojin Chen, Shima Raeesi, Amelie Metz, Roqaie Moqadam, Katherine Chadwick, Yashar Zeighami, Mahsa Dadar · 2026 · medRxiv
36. Association among white matter lesions, rsEEG rhythms, amyloid tau markers, and cognitive status in mild cognitive impairment patients
    Claudio Del Percio, Roberta Lizio, Giuseppe Noce, Matteo Carpi, Susanna Lopez, Filippo Carducci, Mina De Bartolo, Antonio Pio Afragola, Andrea Soricelli, Marco Salvatore et al. · 2026 · Clinical Neurophysiology
37. Cognitive Reserve: White Matter, Microvascular, Glymphatic and Cholinergic Dysfunction in Alzheimer’s Disease
    Paul L. Wood · 2026 · Life
38. Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies
    Osman Corbali, Priyanka Menon, Halil Ibrahim Corbali, Ram Jagannathan, Allan I. Levey · 2026 · Annals of Clinical and Translational Neurology
39. APOE-ε4 links CD8+ T cell infiltration to white matter inflammation in Alzheimer’s disease
    Sem Halters, J. Wildeman, Hannah van der Stok, Susanne M. A. van der Pol, Danielle W.R. Wessels, Manon Karsten, Joke M. M. den Haan, Ronald E. van Kesteren, Annemieke J.M. Rozemüller, Jan Van den Bossche et al. · 2026 · Molecular Neurodegeneration Advances